C
$120–140K / year · Remote · United States
Calyxo
Calyxo, founded in 2016, develops the CVAC System, an all-in-one kidney stone treatment device combining ureteroscopy, laser lithotripsy, irrigation, aspiration and stone collection for single-procedure clearance.
Calyxo is a medical device company founded in February 2016 that develops an all-in-one system for treating kidney stones. Its CVAC System combines ureteroscopy, laser lithotripsy, microjet irrigation, dynamic aspiration and stone collection within a single device, with the aim of achieving complete stone clearance in one procedure rather than across multiple interventions.
The company's flagship procedural approach, the SURE Procedure (Steerable Ureteroscopic Renal Evacuation), is built on the CVAC System and is described as a shift in kidney stone care towards efficient, one-time removal. Technical work spans steerable ureteroscopy, laser lithotripsy, microjet irrigation, dynamic aspiration and stone fragmentation and retrieval - fields within minimally invasive surgery and urology device development.
Calyxo's stated objective is to change how kidney stones are treated, on the premise that the condition should be resolved in a routine, single treatment that leaves both patients and physicians with peace of mind. The leadership team has experience commercialising urology technologies, including the UroLift System, and the company emphasises solutions that are safe, effective and efficient. Kidney stones affect millions of patients annually.